These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 3285483)

  • 21. High-dose megestrol acetate in the treatment of advanced breast cancer.
    Tchekmedyian NS; Tait N; Abrams J; Aisner J
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):44-9. PubMed ID: 3368800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen.
    Bonomi P; Gale M; Von Roenn J; Anderson K; Johnson P; Wolter J; Economou S
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):26-33. PubMed ID: 3368797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer.
    Gill PG; Gebski V; Snyder R; Burns I; Levi J; Byrne M; Coates A
    Ann Oncol; 1993 Nov; 4(9):741-4. PubMed ID: 8280654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Front-line hormonal therapy for patients with advanced breast cancer: a community oncology research program.
    Smalley RV; Sigal RB; Anderson S
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):47-51. PubMed ID: 2259926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Megestrol acetate therapy for advanced breast cancer.
    Gregory EJ; Cohen SC; Oines DW; Mims CH
    J Clin Oncol; 1985 Feb; 3(2):155-60. PubMed ID: 3838187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigations on the nutritional status of advanced breast cancer patients. The influence of long-term treatment with megestrol acetate or tamoxifen.
    Schrijver J; Alexieva-Figusch J; van Breederode N; van Gilse HA
    Nutr Cancer; 1987; 10(4):231-45. PubMed ID: 3432093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential of megestrol acetate in the treatment of cancer cachexia.
    Parnes H; Tait N; Aisner J
    Nutrition; 1989; 5(3):206-9. PubMed ID: 2520291
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II evaluation of megestrol acetate in previously treated patients with advanced breast cancer: relationship of response to previous treatment.
    Blackledge GR; Latief T; Mould JJ; Spooner D; Morrison M
    Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1091-4. PubMed ID: 2946584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose megestrol acetate for the treatment of advanced breast cancer: dose and toxicities.
    Aisner J; Tchekmedyian NS; Moody M; Tait N
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):48-55. PubMed ID: 3589708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weight changes in women with metastatic breast cancer treated with megestrol acetate: a comparison of standard versus high-dose therapy.
    Cruz JM; Muss HB; Brockschmidt JK; Evans GW
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):63-7. PubMed ID: 2259928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status of high-dose progestins in breast cancer.
    Abrams JS; Parnes H; Aisner J
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):68-72. PubMed ID: 2148027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen and progesterone receptor expression of decidual endometrium in a postmenopausal woman treated with tamoxifen and megestrol acetate.
    Cohen I; Shulman A; Altaras M; Tepper R; Cordoba M; Beyth Y
    Gynecol Obstet Invest; 1994; 38(2):127-9. PubMed ID: 7959340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized clinical trial of megestrol acetate versus tamoxifen in paramenopausal or castrated women with advanced breast cancer.
    Ingle JN; Ahmann DL; Green SJ; Edmonson JH; Creagan ET; Hahn RG; Rubin J
    Am J Clin Oncol; 1982 Apr; 5(2):155-60. PubMed ID: 7046412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose progestin therapy for metastatic breast cancer.
    Muss HB; Cruz JM
    Ann Oncol; 1992 Aug; 3 Suppl 3():15-20. PubMed ID: 1390312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose megestrol acetate in the treatment of postmenopausal women with advanced breast cancer.
    Tchekmedyian NS; Tait N; Aisner J
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):20-5. PubMed ID: 3798125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential applications of high-dose megestrol acetate in breast cancer.
    Abrams JS; Gutheil J; Aisner J
    Oncology; 1992; 49 Suppl 2():12-7. PubMed ID: 1461620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary hormonal therapy of advanced breast cancer with megestrol acetate: predictive value of estrogen receptor and progesterone receptor levels.
    Bonomi P; Johnson P; Anderson K; Wolter J; Bunting N; Strauss A; Roseman D; Shorey W; Economou S
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):48-54. PubMed ID: 3975653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroid growth in response to high-dose progestogen.
    Harrison-Woolrych M; Robinson R
    Fertil Steril; 1995 Jul; 64(1):191-2. PubMed ID: 7789558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclic sequential endocrine therapy for advanced breast cancer using a combination of tamoxifen and megestrol acetate.
    Crawford DJ; George WD; Smith DC; Stewart M; Paul J; Leake RE
    Oncology; 1994 Oct; 51 Suppl 1():13-8. PubMed ID: 7970503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose megestrol acetate. A possible treatment for cachexia.
    Tchekmedyian NS; Tait N; Moody M; Aisner J
    JAMA; 1987 Mar; 257(9):1195-8. PubMed ID: 3806918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.